Completed
Equity and Efficacy of Allocation Priority for Liver Transplantation Patients With MELD≥30 in Italy
NCT04530240
- Conditions
- HCC, Liver Transplant Disorder
- Locations
-
Not specified
Clinical trial condition
HCC
Explore clinical trials studying HCC. Study availability and eligibility vary by location and protocol.
97 public trials
30 recruiting studies
HCC trial results
NCT01871545
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +10 more
- Locations
-
- Icahn School of Medicine at Mount Sinai New York, United States
NCT03428321
- Conditions
- HCC
- Locations
-
- Uhmontpellier Montpellier, France
NCT02548780
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +10 more
- Locations
-
- Evgenidio Therapeftirio "Agia Trias" Athens, Greece
- Hospital Clínic i provincial de Barcelona Barcelona, Spain
- Centre Hospitalier Universitaire Vaudois Lausanne, Switzerland
NCT02645981
- Conditions
- HCC
- Locations
-
- The PLA 81 Hospital Nanjing, Jiangsu, China
- West China Hospital Sichuan University Chengdu, Sichuan, China
NCT04173520
- Conditions
- HCC
- Locations
-
Not specified
NCT04069416
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
- Locations
-
Not specified
NCT02471313
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +12 more
- Locations
-
- National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States
NCT02229071
- Conditions
- HCC
- Locations
-
- West China Hospital,SCU Chengdu, Sichuan, China
NCT03875417
- Conditions
- HCC, Quality of Life
- Locations
-
- Department of Surgery "Pietro Valdoni" Roma, Italy